[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 114,310
Sort by:

Ruohonjuuri Oy in Health and Wellness (Finland)

US$ 150.00

Ruohonjuuri Oy expanded from a single outlet marginal retailer to a health and wellness grocery supermarket chain with four outlets. The chain aims to ... and distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...

October 2013 2 pages

Uni-President Enterprises Corp in Health and Wellness (Taiwan)

US$ 150.00

Uni-President Enterprises Corp will continue to employ its extensive expertise in food and retail to remain a key player in health and wellness. As the owner of some of Taiwan’s leading distribution channels, the company is likely to be one of the first to ...

October 2013 2 pages

Thailand Medical Tourism Market (Spending) Analysis & Forecast

US$ 1,290.00

... report titled 'Thailand Medical Tourism Market (Spending) Analysis & Forecast' provides a comprehensive analysis of the Thailand medical tourism market covering in detail ... . All the 15 countries in the report have been studied from 2 viewpoints. Medical Tourists Visits in Thailand from the year 2001-2018 ...

October 2013 112 pages

Smoking Cessation - Data, Analysis & Forecasts to 2023

US$ 3,000.00

GMR Data’s new pharmaceutical report outlines the factors affecting the global smoking cessation market across the forecast period 2013- ... this crucial information this report offers analysis and opinion on current R&D in the smoking cessation sector alongside in depth analysis of the emerging, global e- ...

October 2013 101 pages

GALAPAGOS - Strengthening ties with AbbVie – RA and Cystic Fibrosis + Partnerships of Novel Targets Opportunity Remains

US$ 90.00

... selective JAK1 inhibition by GLPG0634. For more detail, please read our report on GLPG, released on Oct. 4, 2013, titled, 'Strengthening ties with AbbVie – RA and Cystic Fibrosis + Partnerships of Novel Targets Opportunity ...

October 2013 3 pages

ABLYNX - Nanobodies - Turnarond on the Horizon!

US$ 140.00

... of ALX-0061 (PhI/II, Anti-IL6R, RA) with AbbVie under attractive terms (deal value of $840m/~€630m) and news flow in last one year brought back Ablynx (ABLX ... ) and its nanobody platform’s’ potential in the limelight! Though ABLX suffered from several setbacks in 2011, ...

October 2013 7 pages

Japanese Market for Wound and Tissue Management

US$ 6,995.00

... 2012, the Japanese market for wound and tissue management was valued at over $1.5 billion, a 1.6% increase over 2011. The wound and ... period of 10 years (2009 – 2019) for Japan. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment Trend Analysis by Segment ...

October 2013 164 pages

Merck Update: HCV combo, Lambrolizumab and Corporate Restructuring Program

US$ 90.00

Merck announced restructuring (cost efficiency) program which is likely to ... by 2015) announced by the Company through workforce reduction across all functional divisions, head quarter relocation, out ... . More focused attention on therapy areas where Merck has proven its abilities irrespective of unmet need ...

October 2013 3 pages

Global Oncolytic Virus Therapy Pipeline Analysis

US$ 1,500.00

... survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the ... selective without the need for any genetic manipulation. “Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

October 2013 105 pages

Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook

US$ 7,495.00

The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, its impact on the wider health economy is significant and there remains ... , products, late-stage pipeline drugs, product positioning, in the context of COPD market trends. Event Bulletins Benefit from the latest KOL ...

September 2013 157 pages

Physician Views: Life beyond statins – what opportunity for PCSK9 inhibitors?

US$ 695.00

... demonstrated when administered in combination with statin therapy. Given the entrenchment (and genericisation) of most statin therapies, coupled with the subcutaneous ... potential for the emergent PCSK9 inhibitor class. This week's Physician Views poll asks US and 5EU-based cardiologists and general ...

September 2013

Physician Views: The great generic Advair opportunity – a physician perspective

US$ 695.00

... the second pharmacy benefits manager to do so (after CVS Caremark) - see Physician Views Poll Results – US Pulmonologists keen for Breo Ellipta – can payers ... device. This week's Physician Views poll asks pulmonologists and general practitioners based in the US and 5EU markets (where a substitutable generic version of Advair ...

September 2013

Global Testosterone Therapy Market: Trends and Opportunities (2013-2018)

US$ 750.00

... report titled “Global Testosterone Therapy Market”: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global Testosterone Therapy market with detailed analysis of symptoms, diagnosis and treatment of testosterone deficiency. The report majorly focuses on the US testosterone therapy market and also assesses ...

September 2013 60 pages

Physician Views: What opportunity for Gilead Sciences' hepatitis C therapy sofosbuvir before interferon-sparing regiments reach the market?

US$ 695.00

... or ribavirin, thus significantly reducing side-effect burden. A Physician Views poll run by FirstWord in December 2012 (among 74 US-based gastroenterologists ... one-tablet combination of sofosbuvir and ledipasvir). But what of its commercial opportunity in the meantime, assuming the drug is launched in ...

September 2013

Strategies for Working With Real World Data

US$ 395.00

... that is, increasingly, transforming healthcare into ‘reality medicine’ that responds to the real world use of medicines rather than that prescribed by randomised controlled ... to pricing and positioning. How should pharma respond? In Strategies for Working with Real World Data, FirstWord makes a strong case for ...

September 2013 61 pages

Physician Views: What is reaction among urologists, oncologists to the Xtandi PREVAIL data – can it displace Zytiga in the pre-chemotherapy prostate cancer setting?

US$ 695.00

... a cost of up to $1 billion. This week's Physician Views poll will look to assess whether initial KOL and analyst reaction to the top-line PREVAIL ... to prescribe enzalutamide (Xtandi) to on an off-label basis prior to approval? What characteristic would most influence you to prescribe enzalutamide (Xtandi) in ...

September 2013

2013 Healthcare Benchmarks: Home Visits

US$ 107.00

... calls: doctor and dusty medical bag tending a swooning patient. Today's home visits provide a unique perspective on the patient experience while helping ... visits. Download the executive summary of 2013 Healthcare Benchmarks: Home Visits. This all-new research report is supported with dozens of graphs and ...

September 2013 40 pages

Global Hemophilia Market Report: 2013 Edition

US$ 800.00

... new patient registration. The report studies the hemophilia market on a global scale and its various segments. The competition in the global hemophilia market is intense with few large ...

September 2013 56 pages

MEDIVIR - Simeprevir- Good with and without IFN Combinations!

US$ 140.00

... Simeprevir/IFN/RBV combination (TMC435, once daily Protease Inhibitor, PI, R, HCV, partnered with Tibotec/JNJ) in Japan and progress in IFN free combinations with various drugs has helped Medivir ... Though Gilead’s Sofosbuvir/IFN/RBV is not far behind, the real competition is for IFN free combinations and MVIR ...

September 2013 3 pages

ROCHE - Perjeta -First approved therapy in preoperative, early stage, HER2 positive breast cancer; Roche strengthening its breast cancer franchise

US$ 90.00

FDA granted accelerated approval to Roche’s Perjeta for the treatment of high risk, neoadjuvant breast cancer. This is the first drug to be approved for this indication and the approval was based on pathological ...

September 2013 2 pages

U.S. Fertility Clinics & Infertility Services: An Industry Analysis

US$ 995.00

... by Marketdata examines a controversial $3.5 billion healthcare service sector — infertility services. This loosely regulated “baby business” has weathered the ... recession, and more. The study presents the findings of fertility clinic managers, with average costs and number of specific diagnostic procedures ...

September 2013 123 pages

Cia Brasileira de Bebidas in Health and Wellness (Brazil)

US$ 150.00

Cia Brasileira de Bebidas (AmBev) ranked second within health and wellness soft drinks with a value share of 11% in 2012 which was stable compared to the previous year. The company focused investments on attractive categories under higher growth rates like sports drinks and energy drinks under Gatorade and ...

September 2013 3 pages

Basilea pharma - Isavuconazole SECUREs Primary endpoint – Watch out for ACTIVE and VITAL!

US$ 140.00

Basilea pharma (BSLN) along with its partner, Astellas is co-developing antifungal Isavuconazole (PhIII) for invasive fungal infections. Isavuconazole demonstrated non-inferiority vs. voriconazole in its international PhIII, SECURE trial in pts ...

September 2013 5 pages

Food Intolerance in Hong Kong, China

US$ 900.00

... babies, thus spurring the performance of this category. Euromonitor International's Food Intolerance in Hong Kong, China report tracks the developments of health-associated ... and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012 ...

September 2013 21 pages

Greendotdot.com Ltd in Health and Wellness (Hong Kong, China)

US$ 150.00

Greendotdot.com Ltd has been strategically opening new outlets to enhance its brand awareness. Additionally, the company is engaging in various promotional ... and distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

September 2013 2 pages

Food Intolerance in Russia

US$ 900.00

... job during the review period educating their... Euromonitor International's Food Intolerance in Russia report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

September 2013 24 pages

Herbalife International ZAO in Health and Wellness (Russia)

US$ 150.00

... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ... five-year forecasts to assess how the market is predicted to develop. Euromonitor International has over 40 years' experience of publishing market research reports, business ...

September 2013 2 pages

Pedrodiet ZAO in Health and Wellness (Russia)

US$ 150.00

... competitive positioning through this collection of snapshot company profiles. Product coverage: Health and Wellness by Category, Health and Wellness by Prime Positioning, ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

September 2013 2 pages

Private Healthcare Market in Kannur 2013

US$ 950.00

... is placed. Netscribes’ latest market research report titled Private Healthcare Market in Kannur 2013 identifies the healthcare scenario in Kannur. The healthcare landscape in Kannur is dotted with both private and public hospitals ...

September 2013 63 pages

Private Healthcare Market in Perinthalmanna 2013

US$ 950.00

... days after order is placed. Netscribes’ latest market research report titled Private Healthcare Market in Perinthalmanna 2013 identifies the healthcare scenario in Perinthalmanna. Perinthalmanna is a city and a municipality in Malappuram district ...

September 2013 38 pages

NBTY Inc in Consumer Health (World)

US$ 572.00

NBTY is a global leader in vitamins and dietary supplements as well as sports nutrition. Its total consumer health value sales reached US$2.4 billion in 2012. The company ... . Euromonitor International’s NBTY Inc in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The ...

September 2013 35 pages

Novartis AG in Consumer Health (World)

US$ 572.00

... in the world’s largest consumer health market. Globally, its portfolio, though perhaps overly concentrated, continues to perform well. Euromonitor International’s Novartis AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The ...

September 2013 33 pages

Food Intolerance in Japan

US$ 900.00

... , retail value sales reached ¥13 billion in 2012. Euromonitor International's Food Intolerance in Japan report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

September 2013 24 pages

Food Intolerance in South Korea

US$ 900.00

... fashionable to look for gluten-free or diabetic food in South Korea. Euromonitor International's Food Intolerance in South Korea report tracks the developments of health- ... and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

September 2013 24 pages

Food Intolerance in Venezuela

US$ 900.00

... widely accepted than regular baby formula, especially amongst high-income consumers. According to a company source, there is a... Euromonitor International's Food Intolerance in Venezuela report tracks the developments of health-associated product types and the healthy-option positioning of competing brands ...

September 2013 23 pages

Lácteos Los Andes CA in Health and Wellness (Venezuela)

US$ 150.00

Lácteos Los Andes aims to maintain a relevant share in dairy products and soft drinks under the hands of the government. It will continue ... 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, ...

September 2013 2 pages

Agrícola Himalaya Ltda in Health and Wellness (Colombia)

US$ 150.00

Over the forecast period, Agrícola Himalaya will continue to invest in the development of new health and wellness tea and tea-based concentrates ... and distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...

September 2013 2 pages

Britannia Industries Ltd in Health and Wellness (India)

US$ 150.00

... its products accessible, delightful and affordable across all classes and masses of India. Euromonitor International Local Company Profiles are a concise set of briefings ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

September 2013 2 pages

Cooperativa Lechera Colanta SA in Health and Wellness (Colombia)

US$ 150.00

Cooperative Lechera Colanta is a leader in health and wellness packaged food with a strategy of product diversification to reach a wide range of consumers. In addition, as an important strategy to widen distribution, and therefore consumption, of its products, the company continues to increase its ...

September 2013 2 pages

Food Intolerance in Colombia

US$ 900.00

... tapping the niche by introducing lactose-free... Euromonitor International's Food Intolerance in Colombia report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012 ...

September 2013 26 pages

Food Intolerance in India

US$ 900.00

... all continued educating the masses in the media. Euromonitor International's Food Intolerance in India report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

September 2013 22 pages

Food Intolerance in Spain

US$ 900.00

... and healthy diet was the main driver of sales within the food intolerance category in 2012. During the last years of the review ... availability of these products on the shelves of major... Euromonitor International's Food Intolerance in Spain report tracks the developments of health-associated product types ...

September 2013 30 pages

Karnataka Cooperative Milk Producers Federation Ltd in Health and Wellness (India)

US$ 150.00

The company aims to consolidate the gains of dairy development in Karnataka by increasing milk procurement and improving the lives of rural milk producers. The cooperative, modelled on the Anand pattern of milk cooperatives, aims to improve the quality of produce by investing in ...

September 2013 2 pages

Panarro Foods SL in Health and Wellness (Spain)

US$ 150.00

Panarro Foods SL is a manufacturer and distributor of organic products, focusing on fruit/vegetable juice and canned/preserved vegetables. Its strategy is to continue to drive ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

September 2013 2 pages

Santiveri SA in Health and Wellness (Spain)

US$ 150.00

... find in accessing credit. Nevertheless, the strong image and increasing popularity of Santiveri will support... Euromonitor International Local Company Profiles are a concise ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

September 2013 2 pages

Food Intolerance in Portugal

US$ 900.00

... downturn than other areas of health and... Euromonitor International's Food Intolerance in Portugal report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

September 2013 25 pages

Ignoramus - Produtos Naturais Lda in Health and Wellness (Portugal)

US$ 150.00

... continues to promote its health products and educate consumers about the various natural ingredients used in a bid to stimulate demand. Ignoramus - Produtos Naturais aims to increase its share of sales by focusing on raising consumer awareness to widen its consumer base. Euromonitor International Local ...

September 2013 3 pages

Seara Produtos Naturais SA in Health and Wellness (Portugal)

US$ 150.00

The company is focusing its strategy on selling only organic products, mainly in the area of Lisbon through its outlet in the centre of the city. The company aims to increase its awareness among health-conscious consumers that are willing to pay a higher price for organic products and further penetrate the ...

September 2013 2 pages

La Vie Joint Venture Co in Health and Wellness (Vietnam)

US$ 150.00

La Vie Joint Venture will continue to maintain a large marketing and advertising budget to keep its brand constantly well known among consumers. At the same time, it will also upgrade its manufacturing capability to be able to cater to more people, and expand its distribution network throughout the ...

September 2013 2 pages

Filters

Search

Categories

111,821
370
94
240
545
1,146
94

Publishers

179
1
123
116
2,357
101
25
102
98
2,527
195
23
40
8,299
68
563
682
34
29,954
248
501
3,036
1
1
2
3
16
257
537
361
106
1
1,357
60
1,696
8
8,921
1,966
4
3,674
1,550
19
1
321
4,852
2,744
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
277
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
34
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
649
1
4
6
1
9
1
3
5
1
1
1
90
2
4
4
1
82
15
1,158
1
3
1
17
227
128
16
4
397
3
74
2
6
5
10
1
3
118
33
336
203
47
474
7
45
1
25
13
138
2
4

Regions

58
56
56
48
35
35
31
30
29
29
29
26
26
25
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,693
51
52
3
34
2
2
1,178
115
172
26
33
94
14
49
45
28
18
58
25
23
39
23
39
24
14
49
28
34
130
46
60
63
198
49
17
52
39
30
44
43
37
32
19
55
145
34
30
28
17
17
16
14
96
40
133
53
45
29
15
457
1,819
67
921
758
180
2,003
101,671

Price

Date

Pages

Offers

98
23
1
2,731
276
1
1